Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian approach to average bioequivalence using Bayes' factor.

Pulak Ghosh1, Ravindra Khattree

  • 1Department of Mathematics and Statistics, Oakland University, Rochester, Michigan 48309-4485, USA. pghosh@oakland.edu

Journal of Biopharmaceutical Statistics
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Template-independent enzymatic functionalization of DNA oligonucleotides with environment-sensitive nucleotide probes using terminal deoxynucleotidyl transferase.

Nucleic acids research·2025
Same author

Structures of a DNA Polymerase Caught while Incorporating Responsive Dual-Functional Nucleotide Probes.

Angewandte Chemie (International ed. in English)·2024
Same author

Association Between a State-Level Fat Tax and Fast Food Purchases.

JAMA network open·2023
Same author

C. R. Rao, statistician who transformed data analytics (1920-2023).

Nature·2023
Same author

A multiplicative structural nested mean model for zero-inflated outcomes.

Biometrika·2023
Same author

Microenvironment-Sensitive Fluorescent Nucleotide Probes from Benzofuran, Benzothiophene, and Selenophene as Substrates for DNA Polymerases.

Journal of the American Chemical Society·2022
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

A new Bayes' factor method improves drug bioequivalence testing, addressing drawbacks in current bioavailability studies and better controlling consumer risk. This approach enhances drug development and regulatory assessment.

Area of Science:

  • Pharmacokinetics and Drug Development
  • Biostatistics and Regulatory Science

Background:

  • Bioavailability studies are crucial for assessing bioequivalence between drug formulations.
  • Current bioequivalence assessment methods have significant drawbacks, including inadequate control of consumer risk.

Purpose of the Study:

  • To propose a novel methodology for average bioequivalence using Bayes' factor.
  • To address limitations in existing bioequivalence testing protocols.

Main Methods:

  • Application of Bayes' factor for average bioequivalence.
  • Comparison with existing methods using real Food and Drug Administration (FDA) data.
  • Exploration of results through simulation studies.

Main Results:

Related Experiment Videos

  • The proposed Bayes' factor methodology offers a viable alternative for average bioequivalence assessment.
  • The new approach demonstrates potential for improved control over consumer risk compared to current methods.

    • Conclusions:

    • The Bayes' factor approach provides a statistically sound and potentially more reliable method for bioequivalence testing.
    • This methodology can enhance the accuracy and safety of drug formulation comparisons in development and regulatory settings.